Grace Therapeutics (GRCE) Q3 2026 Earnings

Aug 13Confirmed
Q3 2025
Q4 2025
Q1 2026
Q3 2026
-0.91
-0.63
-0.34
-0.06

Details

Expected EPS
-0.1293
Actual EPS
-0.91
Surprise EPS
-0.78
Surprise Percent
-603.79%

Description

⁨Grace Therapeutics⁩ (⁦GRCE⁩) has reported earnings of ⁦-0.91⁩ per share for ⁦Q3 2026⁩.

0 Comments

Share your thoughts